Anticoagulation Resumption After Intracerebral Hemorrhage

PURPOSE OF REVIEW: Decision-making on resuming oral anticoagulant (OAC) after intracerebral hemorrhage (ICH) evokes significant debate among clinicians. Such patients have been excluded from randomized clinical trials. This review article provides a comprehensive summary of the evidence on anticoagu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan-guang, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Cardiovascular Disease and Stroke (S. Prabhakaran, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960649/
https://www.ncbi.nlm.nih.gov/pubmed/29781063
http://dx.doi.org/10.1007/s11883-018-0733-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960649/
https://www.ncbi.nlm.nih.gov/pubmed/29781063
http://dx.doi.org/10.1007/s11883-018-0733-y

Ejemplares similares